Source:http://linkedlifedata.com/resource/pubmed/id/18381123
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-4-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0079-6468
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-28
|
pubmed:meshHeading |
pubmed-meshheading:18381123-Drug Discovery,
pubmed-meshheading:18381123-HIV Infections,
pubmed-meshheading:18381123-HIV Integrase Inhibitors,
pubmed-meshheading:18381123-Humans,
pubmed-meshheading:18381123-Protein Binding,
pubmed-meshheading:18381123-Pyrrolidinones,
pubmed-meshheading:18381123-Structure-Activity Relationship
|
pubmed:year |
2008
|
pubmed:articleTitle |
The discovery of raltegravir, an integrase inhibitor for the treatment of HIV infection.
|
pubmed:affiliation |
IRBM, via Pontina Km 30,600, Pomezia, Rome 00040, Italy.
|
pubmed:publicationType |
Journal Article,
Review
|